Peter van Koetsveld

Peter van Koetsveld is a researcher in the Department of Internal Medicine at Erasmus Medical Center, with an extensive publication record of 110 research outputs. His work primarily focuses on endocrine disorders, particularly neuroendocrine tumors and pituitary diseases.

His research interests center on somatostatin receptor biology, pituitary adenomas, and the gut microbiome's role in neuroendocrine tumors. Key areas include Cushing's disease treatment, octreotide therapy, and molecular mechanisms of growth hormone regulation. His work bridges clinical endocrinology with molecular biology approaches.

Analysis of his recent publications reveals a consistent focus on somatostatin receptor subtypes, particularly SSTR2, and their therapeutic targeting. His research spans from basic molecular studies to clinical trials, with particular attention to diagnostic and therapeutic applications for neuroendocrine tumors. The gut microbiome has emerged as a significant new research direction in his recent work.

Peter van Koetsveld maintains strong collaborative relationships with researchers including Hofland L.J., Feelders R.A., and de Herder W.W., forming a productive research group focused on endocrine oncology. His work receives attention in academic circles with citations across multiple publications and engagement on academic platforms.